Sarah Vaselenak
2PUBLICATIONS
4CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (2)
Sort by Publication Date:
|Apr 23, 2025
Cost-Effectiveness of Adjuvant Alectinib Versus Chemotherapy for Patients with Resectable, ALK-positive Non-small Cell Lung Cancer in Canada.Nick Jovanoski, Sarah Vaselenak, Andrew Hogan
|Jun 26, 2024
Impact of Adjuvant Atezolizumab on Recurrences Avoided and Treatment Cost Savings for Patients with Stage II-IIIA Non-Small Cell Lung Cancer in Canada.Quincy Chu, Kaushik Sripada, Sarah Vaselenak
Pageof 1
